Evidence map›Paper›PMID 38583461›Full record

Trial reportThe lancet. HIV2024

Voucher incentives to improve viral suppression among HIV-positive people who inject drugs and men who have sex with men in India: a cluster randomised trial.

Sunil S Solomon, Allison M McFall, Aylur K Srikrishnan, Vinita Verma, Santhanam Anand, Rifa T Khan, Bhawani Singh Kushwaha, Canjeevaram Vasudevan, Shanmugam Saravanan, Nandagopal Paneerselvam and 5 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The lancet. HIV, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02969915 (Strategies to Improve the HIV Care Continuum Among Key Populations in India), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02969915 nacompletednot on this map

Strategies to Improve the HIV Care Continuum Among Key Populations in India

TypeinterventionalSponsorJohns Hopkins UniversityRan2017 to 2024Enrolled2,314ConditionsHIV InfectionsArmsIncentives, Integrated Care Centers
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Sunil S SolomonDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: sss@jhmi.edu.
Allison M McFallDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Aylur K SrikrishnanYR Gaitonde Centre for AIDS Research and Education, Chennai, India.
Vinita VermaNational AIDS Control Organisation, Ministry of Health and Family Welfare, New Delhi, India.
Santhanam AnandYR Gaitonde Centre for AIDS Research and Education, Chennai, India.
Rifa T KhanYR Gaitonde Centre for AIDS Research and Education, Chennai, India.
Bhawani Singh KushwahaNational AIDS Control Organisation, Ministry of Health and Family Welfare, New Delhi, India.
Canjeevaram VasudevanYR Gaitonde Centre for AIDS Research and Education, Chennai, India.
Shanmugam SaravananYR Gaitonde Centre for AIDS Research and Education, Chennai, India.
Nandagopal PaneerselvamYR Gaitonde Centre for AIDS Research and Education, Chennai, India.
Muniratnam Suresh KumarYR Gaitonde Centre for AIDS Research and Education, Chennai, India.
Chinmoyee DasNational AIDS Control Organisation, Ministry of Health and Family Welfare, New Delhi, India.
David D CelentanoDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Shruti H MehtaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Gregory M LucasDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Strategies to improve the HIV care continuum among key populations in IndiaR01DA041034 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M, MEHTA, SHRUTI H · 2015 to 2021
$6.7M
Treatment outcomes and comorbidity in HIV-infected IDUK24DA035684 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M · 2014 to 2024
$1.5M
NIAID NIH HHS P30 AI094189NIDA NIH HHS K24 DA035684NIDA NIH HHS R01 DA041034
6 · The paper itself

Abstract

backgroundProgress on HIV treatment outcomes for people who inject drugs and men who have sex with men in India has been slow compared with that in other populations. We assessed whether HIV treatment incentives would improve outcomes among these groups.

methodsWe did a matched-pair, cluster randomised trial in 16 sites (eight for people who inject drugs and eight for men who have sex with men) across 15 cities in India. We recruited cohorts of HIV-positive people who inject drugs or men who have sex with men who were antiretroviral therapy (ART)-naive or had less than 12 months of ART exposure. We randomised sites to provide incentives or usual care. At intervention sites, we provided incentive vouchers, which could be exchanged for food or household goods, for attending motivational interviewing sessions and timely appointments at government ART clinics. An ART-naive participant meeting all targets could earn the equivalent to 14 days' wages over 12 months. The primary outcome was survival with viral suppression at 12 months. We used an intention-to-treat analytic approach appropriate for matched-pair cluster randomised trials, adjusting for baseline viral suppression. This study was registered with ClinicalTrials.gov, NCT02969915, and is complete.

findingsBetween Oct 30, 2017, and Oct 12, 2018, we recruited 1200 people who inject drugs and 1114 men who have sex with men living with HIV. Among people who inject drugs, 154 (12·8%) identified as female gender and 1046 (87·2%) as male. The site median percentage of participants earning one or more incentives was 96·1% (IQR 93·7-98·1). At 12 months, HIV viral suppression was 31·9% (n=383) among people who inject drugs and 52·1% (n=580) among men who have sex with men. The incentive intervention was not associated with significantly improved survival with viral suppression compared with usual care (adjusted prevalence difference 9·6 percentage points, 95% CI -4·4 to 23·7).

interpretationDespite high intervention engagement, incentives did not improve survival with viral suppression among people who inject drugs and men who have sex with men living with HIV in India. The poor outcomes overall underscore the need for innovative, multilevel approaches to engage marginalised people living with HIV in low-income and middle-income settings.

fundingUS National Institutes of Health, Elton John AIDS Foundation.

Indexed as

HIV InfectionsHomosexuality, MaleMotivationSubstance Abuse, IntravenousAdultAnti-HIV AgentsFemaleHumansIndiaMaleMotivational InterviewingSexual and Gender MinoritiesTreatment OutcomeViral LoadAnti-HIV Agents

Identifiers

PMID38583461
PMCPMC11177221

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.